James Darecca

Insider Reports History

Location
Boston, MA
Signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. D'Arecca
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Darecca:

Form 4 holding Chief Financial Officer

TherapeuticsMD, Inc.

Security class
Restricted Stock Units
Shares / value
434,333
Estimated value
$1,580,147
Report date
10 Aug 2021
Price
$3.64
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

TherapeuticsMD, Inc.

Security class
Common Stock
Shares / value
123,830
Estimated value
$277,255
Report date
12 Aug 2021
Price
$2.24
Ownership
Direct
Form 4 holding EVP, Chief Financial Officer

HAEMONETICS CORP

Security class
Non-qualified Stock Option (Right to Buy)
Shares / value
15,396
Estimated value
Report date
16 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by James Darecca

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .